id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-338403-mfde6juv	Li, Bo	Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China	2020-03-11		.txt	text/plain	3419	181	50	METHODS: A meta-analysis of eligible studies that summarized the prevalence of cardiovascular metabolic diseases in COVID-19 and compared the incidences of the comorbidities in ICU/severe and non-ICU/severe patients was performed. Inclusion criteria are as follows: (1) comparative studies: randomised controlled trials RCTs or non-RCTs published in English; (2) study population: more than ten participants were included in the study; (3) study intervention: patients in the studies should be confirmed to have been infected by 2019 novel coronavirus; (4) parameters: the comorbidities of cardiovascular metabolic diseases and the outcome of cardiac injury should be given. Systematic analysis of studies that described the epidemiological and clinical features of COVID-19 cases and reported the prevalence of cardiovascular metabolic diseases as well as the impact on cardiac injury in the infectious disease, has identified six reports with 1527 patients ( Table 1 ).	./cache/cord-338403-mfde6juv.txt	./txt/cord-338403-mfde6juv.txt